Skip to main content

Table 1 Patients characteristics (N = 1001)

From: Increased risk of non-AIDS-defining cancers in Asian HIV-infected patients: a long-term cohort study

Median age (IQR), years 38 (31–48)
20–39 551 (55.0%)
40–49 239 (23.9%)
50–59 139 (13.9%)
60–69 56 (5.6%)
≥ 70 17 (1.7%)
Sex (male) 942 (94.1%)
Alcohol drinker 557 (55.6%)
Smoker 421 (42.1%)
Year of entry
 1997–2001 267 (26.7)
 2002–2006 331 (33.1)
 2007–2011 309 (30.9)
 2012–2015 94 (9.4)
HIV-related factors
 HIV risk group
  MSM 753 (75.2%)
  Heterosexuals 123 (12.3%)
  Blood transmissiona 99 (9.9%)
  Injection drug use 8 (0.8%)
  Unknown 18 (1.8%)
  Median CD4 (IQR), cells/μL 100 (30–184)
  CD4 < 200, cells/μL 777 (77.6)
  200–499 209 (20.9)
   ≥ 500 15 (1.5)
  Median HIV VL (IQR), copies/mL 63,000 (5400-310,000) (4.4–5.6)
  HIV VL < 400, copies/mL 166 (16.6)
  400–75,000 360 (36.0)
   > 75,000 475 (47.5)
  On antiretroviral therapy 312 (31.2)
  HBV infection alone 151 (15.1%)
  HCV infection 145 (14.5%)
  HBV and HCV co-infection 15 (1.5%)
Co-morbidities
 Hypertension 102 (10.2%)
 Dyslipidemia 129 (12.9%)
 Diabetes mellitus (uncomplicated) 80 (8.0%)
 Diabetes mellitus (end-organ damage) 32 (3.2%)
 Myocardial infarction 9 (0.9%)
 Congestive heart failure 15 (1.5%)
 Peripheral vascular disease 2 (0.2%)
 Cerebrovascular disease 16 (1.6%)
 Dementia 14 (1.4%)
 COPD 7 (0.7%)
 Connective tissue disease 2 (0.2%)
 Peptic ulcer disease 31 (3.1%)
 Chronic kidney disease 64 (6.4%)
 Hemiplegia 1 (0.1)
 Chronic liver disease 141 (14.1%)
 Mild 105 (10.5%)
 Moderate to severe 36 (3.6%)
  1. Note. aA total of 96% had hemophilia
  2. Abbreviations: HBV hepatitis B virus, HCV hepatitis C virus, HAART highly active anti-retroviral therapy, IQR interquartile range, MSM men who have sex with men, IDU injection drug users, VL viral load, COPD chronic obstructive pulmonary disease, NADCs non-AIDS-defining cancers